Martinez V, Belbachir A, Jaber A, et al. The influence of timing of administration on the analgesic efficacy of parecoxib in orthopedic surgery[J] . Anesth Analg,2007,104(6):1521-1527.
Loop T, Prebe H J. Recovery after anesthesia with remifentanil combined with propofol, desflurane, or sevoflurane for otorhinolaryngeal surgery [J]. Anesth Analg, 2000, 91(1):123-129.
Lenz H, Raeder J, DraegniI T, et al. Effects of COX inhibition on experimental pain and hyperalgesia during and after remifentanil infusion in humans[J]. Pain, 2011, 152(6): 1289-1297.
Chen L C,Elliott R A. Systemic review of the analgesic efficacy and tolerability of COX-2 inhibitors in postoperative pain control[J]. J Clin Pharm Ther,2004,29(3):215-229.
[16]
Benito J,Aguado D,Abreu M B,et al. Remifentanil and cyclooxygenase inhibitors interactions in the minimum alveolar concentration of sevoflurane in the rat [J]. Br J Anaesth,2010,105(6):810-817.
[17]
Kranke P,Morin A M,Roewer N. Patients global evaluation of analgesia and safety of injected parecoxib for postoperative pain a quantitative systematic review [J]. Anesth Analg, 2004, 99(3):797-806.
[18]
Malan T P, Marsh G, Hakki S I, et al. Parecoxib sodium, a parenteral cyclooxygenase2 selective inhibitor, improves morphine analgesia and is opioid-sparing following total hip arthroplasty [J]. Anesthesiology, 2003, 98(4):950-956.
[19]
Barton S F, Langeland F F, Snabes M C, et al. Efficacy and safety of intravenous parecoxib sodium in relieving acute postoperative pain following gynecologic laparotomy surgery[J].Anesthesiology,2002,97(2):306-314.
2017, Vol. 28 
